Aptevo Therapeutics Inc expected to post a loss of $83.20 a share - Earnings Preview

Aptevo Therapeutics

04/08/2025 14:49

Aptevo Therapeutics Inc APVO.OQ APVO.O is expected to  show no change in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Aptevo Therapeutics Inc is for a loss of $83.20 per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Aptevo Therapeutics Inc is $420.00, about 99.4% above its last closing price of $2.68

This summary was machine generated August 4 at 13:49 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)